Home/Filings/4/0001062993-22-005780
4//SEC Filing

KOBLISH ANTONY 4

Accession 0001062993-22-005780

CIK 0001561921other

Filed

Feb 24, 7:00 PM ET

Accepted

Feb 25, 5:11 PM ET

Size

7.0 KB

Accession

0001062993-22-005780

Insider Transaction Report

Form 4
Period: 2022-02-24
KOBLISH ANTONY
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2022-02-24+46,500240,924 total
  • Award

    Stock Option (Right to Buy)

    2022-02-24+79,50079,500 total
    Exercise: $11.98Exp: 2032-02-24Common Stock (79,500 underlying)
Footnotes (2)
  • [F1]These restricted stock units will vest in four equal annual installments beginning on February 24, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
  • [F2]The option vests 25% on February 24, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Issuer

TELA Bio, Inc.

CIK 0001561921

Entity typeother

Related Parties

1
  • filerCIK 0001195881

Filing Metadata

Form type
4
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 5:11 PM ET
Size
7.0 KB